cytarabine has been researched along with Cerebellar Diseases in 33 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 19 (57.58) | 18.7374 |
1990's | 8 (24.24) | 18.2507 |
2000's | 5 (15.15) | 29.6817 |
2010's | 1 (3.03) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Corral Corral, Í; de Felipe Mimbrera, A; Jiménez Martín, A; Sainz de la Maza Cantero, S | 1 |
Ifrah, N; Leboucher, B; Pellier, I; Rachieru, P; Rialland, X | 1 |
Bleyer, A | 1 |
Agarwal, RP; Lopez, JA | 1 |
Lazarus, HM | 1 |
Abe, Y; Nakao, K; Ohota, S; Ohoya, N; Shimada, M; Yamano, T | 1 |
Beaudreuil, J; Casassus, P; Guillevin, L; Jarrousse, B; Lortholary, O; Salama, J | 1 |
Chim, CS; Kwong, YL | 1 |
Forman, SJ; Hinton, DR; Openshaw, H; Slatkin, NE; Stein, AS | 1 |
Olavarria, E; Prieto, E; Roman, A | 1 |
Aird, W; Amrein, P; MacNeill, K; Neuberg, D; Shulman, LN; Sternberg, DW; Thompson, L | 1 |
Arber, D; Dagis, A; Forman, SJ; Margolin, KA; Nademanee, A; Niland, J; O'Donnell, MR; Parker, PM; Schmidt, GM; Slovak, ML; Smith, EP; Snyder, DS; Somlo, G; Stein, AS | 1 |
Friedman, JH; Grace, J; Shetty, N; Zawacki, T | 1 |
Bosco, L; Bufton, MG; Faich, GA; Flynn, B; Gerstman, BB; Jolson, HM; Rinsler, SS; Simmons, WD; Stadel, BV; Williams, E | 1 |
Crocker, I; Dobbs, CK; Gordon, DS; Heffner, LT; Reynolds, R; Sternberg, P; Vogler, WR; Winton, EF | 1 |
Hasle, H | 1 |
Mahaney, FX | 1 |
Bologna, S; Link, MP; Miller, L; Parker, BR | 1 |
Boesen, P; Fallingborg, J; Spaun, E | 1 |
Carter, RT; Cersosimo, RJ; Coderre, M; Karp, DD; Matthews, SJ | 1 |
Durmaz, R; Ucar, K | 1 |
Cold, S | 1 |
Castellanos, AM; Glass, JP; Keating, MJ; Ventura, GJ | 1 |
Talstad, I; Thordarson, H | 1 |
Fisher, AJ; Lobell, M; Sylvester, RK | 1 |
Adelstein, DJ; Brown, RA; Cassileth, PA; Coccia, PF; Herzig, GP; Herzig, RH; Hines, JD; Lazarus, HM; Strandjord, S; Wolff, SN | 1 |
Fay, JW; Herzig, GP; Herzig, RH; Hines, JD; Phillips, GL; Wolff, SN | 1 |
Capizzi, RL; Powell, BL | 1 |
Durie, BG; Garewal, H; Greenberg, B | 1 |
Barnett, MJ; Butler, MG; Ganesan, TS; Lister, TA; Richards, MA; Rohatiner, AZ; Slevin, ML; Smith, BF; Waxman, JH | 1 |
Benger, A; Browman, GP; Preisler, HD; Walker, IR | 1 |
Dworkin, LA; Fuchs, PC; Goldman, RD; Zivin, LS | 1 |
Estey, EH; Fields, WS; Hwang, TL; Yung, WK | 1 |
1 review(s) available for cytarabine and Cerebellar Diseases
Article | Year |
---|---|
Cerebellar toxicity during cytarabine therapy associated with renal insufficiency.
Topics: Acute Kidney Injury; Aged; Cerebellar Diseases; Cytarabine; Dose-Response Relationship, Drug; Humans; Lung Neoplasms; Male; Risk Factors | 1990 |
1 trial(s) available for cytarabine and Cerebellar Diseases
Article | Year |
---|---|
Central nervous system toxicity of high-dose cytosine arabinoside.
Topics: Adolescent; Adult; Aged; Central Nervous System Diseases; Cerebellar Diseases; Clinical Trials as Topic; Cytarabine; Dose-Response Relationship, Drug; Drug Evaluation; Epilepsy, Tonic-Clonic; Female; Humans; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Lymphoma; Male; Middle Aged; Nystagmus, Pathologic; Syndrome; Tremor | 1985 |
31 other study(ies) available for cytarabine and Cerebellar Diseases
Article | Year |
---|---|
Cerebellar toxicity due to cytarabine: A series of 4 cases.
Topics: Aged; Antimetabolites, Antineoplastic; Cerebellar Diseases; Cytarabine; Dose-Response Relationship, Drug; Humans; Liver Failure, Acute; Magnetic Resonance Imaging; Middle Aged | 2016 |
Flushing out of cerebrospinal fluid as a therapy for acute cerebellar dysfunction caused by high dose of cytosine arabinoside: a case report.
Topics: Adolescent; Antimetabolites, Antineoplastic; Cerebellar Diseases; Cerebrospinal Fluid; Cytarabine; Humans; Leukemia, Myeloid, Acute; Male | 2006 |
"Flushing out" cytosine arabinoside from CSF to reverse neurotoxicity.
Topics: Adolescent; Antimetabolites, Antineoplastic; Cerebellar Diseases; Cerebrospinal Fluid; Cytarabine; Humans; Leukemia, Myeloid, Acute; Male | 2007 |
Acute cerebellar toxicity after high-dose cytarabine associated with CNS accumulation of its metabolite, uracil arabinoside.
Topics: Arabinofuranosyluracil; Carcinoma, Small Cell; Cerebellar Diseases; Cytarabine; Humans; Lung Neoplasms; Male; Middle Aged; Uridine | 1984 |
Acute cerebellar dysfunction with high-dose Ara-C therapy.
Topics: Acute Disease; Adult; Cerebellar Diseases; Cytarabine; Humans; Leukemia | 1984 |
Formation of heterotopic granule cell in mouse cerebellum after neonatal administration of cytosine arabinoside.
Topics: Age Factors; Animals; Axons; Cell Movement; Cerebellar Cortex; Cerebellar Diseases; Cerebellum; Cytarabine; Mice; Microscopy, Electron; Purkinje Cells; Synapses | 1980 |
[Cerebellar toxicity of cytosine-arabinoside in a young man following cerebral anoxia].
Topics: Adult; Antimetabolites, Antineoplastic; Cerebellar Diseases; Cytarabine; Humans; Hypoxia, Brain; Male | 1995 |
Cerebellar toxicity with medium-dose cytarabine in a young patient with renal insufficiency.
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Diseases; Cytarabine; Daunorubicin; Female; Humans; Kidney; Kidney Failure, Chronic; Leukemia, Myeloid; Lupus Nephritis; Mitoxantrone | 1996 |
Acute polyneuropathy after high dose cytosine arabinoside in patients with leukemia.
Topics: Acute Disease; Adult; Antimetabolites, Antineoplastic; Cerebellar Diseases; Cytarabine; Demyelinating Diseases; Female; Humans; Leukemia; Male; Middle Aged; Peripheral Nervous System Diseases; Retrospective Studies | 1996 |
Retreatment with low-dose cytarabine in patients with previous central nervous system toxicity.
Topics: Cerebellar Diseases; Cytarabine; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged | 1997 |
Treatment of patients with recurrent and primary refractory acute myelogenous leukemia using mitoxantrone and intermediate-dose cytarabine: a pharmacologically based regimen.
Topics: Adult; Age Factors; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Cerebellar Diseases; Cytarabine; Death, Sudden, Cardiac; Disease-Free Survival; Drug Eruptions; Exanthema; Female; Humans; Injections, Intravenous; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Neutropenia; Remission Induction; Thrombocytopenia; Treatment Outcome | 2000 |
High-dose cytosine arabinoside and daunorubicin induction therapy for adult patients with de novo non M3 acute myelogenous leukemia: impact of cytogenetics on achieving a complete remission.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Diseases; Chromosome Aberrations; Chromosome Deletion; Chromosome Inversion; Chromosomes, Human; Chromosomes, Human, Pair 7; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Myeloid; Logistic Models; Male; Middle Aged; Prognosis; Remission Induction; Retrospective Studies; Sepsis; Translocation, Genetic; Treatment Outcome | 2000 |
Cerebellar toxicity of cytosine arabinoside: clinical and neuropsychological signs.
Topics: Adult; Cerebellar Diseases; Cerebellum; Cytarabine; Humans; Magnetic Resonance Imaging; Male | 2000 |
Clustering of adverse drug events: analysis of risk factors for cerebellar toxicity with high-dose cytarabine.
Topics: Adolescent; Adult; Aged; Cerebellar Diseases; Cerebellum; Cohort Studies; Creatinine; Cytarabine; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk Factors | 1992 |
Ophthalmological and other toxicities related to cytosine arabinoside and total body irradiation as preparative regimen for bone marrow transplantation.
Topics: Bone Marrow Transplantation; Cerebellar Diseases; Cyclosporins; Cytarabine; Diarrhea; Evaluation Studies as Topic; Female; Georgia; Humans; Leukemia; Lymphoma; Male; Methotrexate; Myelodysplastic Syndromes; Preoperative Care; Remission Induction; Retinitis; Survival Rate; Transplantation, Autologous; Transplantation, Homologous; Whole-Body Irradiation | 1990 |
Physicians warned of high-dose cytarabine.
Topics: Cerebellar Diseases; Cytarabine; Drug Industry; Humans; Therapeutic Equivalency; United States; United States Food and Drug Administration | 1990 |
Cerebellar atrophy caused by high-dose cytosine arabinoside: CT and MR findings.
Topics: Atrophy; Cerebellar Diseases; Cerebellum; Child, Preschool; Cytarabine; Humans; Leukemia, Promyelocytic, Acute; Magnetic Resonance Imaging; Male; Tomography, X-Ray Computed | 1989 |
Severe persistent cerebellar dysfunction complicating cytosine arabinoside therapy.
Topics: Adult; Cerebellar Diseases; Cytarabine; Female; Humans; Leukemia, Myeloid, Acute; Purkinje Cells | 1988 |
Acute cerebellar syndrome, conjunctivitis, and hearing loss associated with low-dose cytarabine administration.
Topics: Aged; Cerebellar Diseases; Conjunctivitis; Cytarabine; Hearing Disorders; Humans; Male; Primary Myelofibrosis | 1987 |
High-dose chemotherapy regimens.
Topics: Cerebellar Diseases; Cytarabine; Half-Life; Humans; Leukemia, Myeloid, Acute; Oxygen Inhalation Therapy | 1986 |
Cerebellar dysfunction during high dose cytosine arabinoside therapy in a case of acute myelogenous leukaemia.
Topics: Cerebellar Diseases; Cytarabine; Dose-Response Relationship, Drug; Female; Humans; Leukemia, Myeloid, Acute; Middle Aged | 1986 |
Reversible bilateral lateral rectus muscle palsy associated with high-dose cytosine arabinoside and mitoxantrone therapy.
Topics: Adult; Cerebellar Diseases; Cytarabine; Female; Humans; Leukemia, Myeloid, Acute; Mitoxantrone; Ophthalmoplegia | 1986 |
Acute meningitis and cerebellar dysfunction complicating high-dose cytosine arabinoside therapy.
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Diseases; Cytarabine; Female; Humans; Leukemia, Lymphoid; Meningitis; Meningitis, Aseptic | 1986 |
Cytarabine-induced cerebellar syndrome: case report and literature review.
Topics: Cerebellar Diseases; Cytarabine; Humans; Leukemia, Myeloid; Male; Middle Aged | 1987 |
Cerebellar toxicity with high-dose cytosine arabinoside.
Topics: Adolescent; Adult; Age Factors; Aged; Cerebellar Diseases; Child; Child, Preschool; Cytarabine; Female; Humans; Infant; Leukemia; Lymphoma; Male; Middle Aged | 1987 |
Central nervous system effects of high-dose cytosine arabinoside.
Topics: Adult; Age Factors; Aged; Cerebellar Diseases; Cytarabine; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Leukemia; Middle Aged | 1987 |
Sequential high-dose ara-C and asparaginase versus high-dose ara-C alone in the treatment of patients with relapsed and refractory acute leukemias.
Topics: Acute Disease; Asparaginase; Cerebellar Diseases; Cytarabine; Diarrhea; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Humans; Leukemia; Neoplasm Recurrence, Local | 1987 |
High-dose cytosine arabinoside, daunomycin and 6-thioguanine in relapsed or refractory acute nonlymphocytic leukemia.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Diseases; Cytarabine; Daunorubicin; Gastrointestinal Diseases; Humans; Leukemia; Recurrence; Remission Induction; Thioguanine | 1987 |
Clinical evidence of a cumulative effect of high-dose cytarabine on the cerebellum in patients with acute leukemia: a leukemia intergroup report.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Diseases; Cytarabine; Female; Humans; Leukemia; Male; Middle Aged | 1985 |
Cerebellar toxicity following high-dose cytosine arabinoside.
Topics: Ataxia; Cerebellar Diseases; Cytarabine; Dysarthria; Humans; Leukemia; Male; Middle Aged; Purkinje Cells | 1985 |
Central nervous system toxicity with high-dose Ara-C.
Topics: Adolescent; Adult; Aged; Brain Diseases; Central Nervous System Diseases; Cerebellar Diseases; Cytarabine; Female; Humans; Leukemia; Male; Middle Aged | 1985 |